1 DECISION AID TOOL PROSTATE CANCER SCREENING WITH PSA TESTING This booklet is what is often called a decision aid. The goals of a decision aid are to help people better understand their medical choices and to help them make the best medical decision possible for their situation. This decision aid is for men who are concerned about prostate cancer and are trying to decide whether or not to receive a blood test, known as the prostate-specific antigen (PSA) test that is used to screen for prostate cancer. PSA-based screening is often used to screen healthy men for prostate cancer, and may be included as part of a routine check-up. The PSA test can be done with or without other tests such as a digital rectal exam. Visit and/or ask your doctor for more information about other tests to screen for prostate cancer. The goal of this decision aid is to help men and doctors make shared and informed decisions about prostate cancer screening. It is based on recommendations from Screening for Prostate Cancer with Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion. Use of this decision aid is voluntary. The decision aid is divided into two sections: 1. Learning the risks and benefits of your options, with your doctor. 2. Help for thinking through the decision, on your own. The first time you read this decision aid, your doctor or nurse should be available to help you understand the information, and any family members or friends you would like to include. You may also take this document home after reviewing it with your doctor or nurse. This guide contains numbers or statistics which may predict the course of prostate cancer. If you are not comfortable with this type of information, you may prefer not to use this decision aid. What role do you prefer in making this choice? I prefer to share the decision with I prefer to decide myself after hearing the views of I prefer that someone else decides I prefer to decide on my own If help is desired, from whom? Doctor Spouse/Partner Children Other family member(s) Other person This practice tool for physicians is a decision aid derived from an ASCO provisional clinical opinion. The provisional clinical opinion and this decision aid are not intended to substitute for the independent professional judgment of the treating physician. Provisional clinical opinions do not account for individual variation among patients and may not reflect the most recent evidence. This decision aid does not recommend any particular product or course of medical treatment. Use of the provisional clinical opinion and this tool is voluntary. The full provisional clinical opinion and additional resources are available at
2 THE BOTTOM LINE This decision to get PSA tested is not a simple one. Weighing the possible benefits against the possible risks is important. It is ultimately up to each man, after hearing all the information from their doctor. The main benefit of PSA testing is that for some men it leads to the identification and treatment of harmful prostate cancer earlier when treatment is more effective. The main risk of PSA testing is that for some men it leads to additional invasive tests, treatments, and side effects that turn out to be unnecessary. This is because some prostate cancers detected would never have caused a problem in their lifetimes. Most PSA tests come back as normal and this knowledge can provide peace of mind around your risk of having prostate cancer. It s important to think about what you will do if your PSA level comes back as suspicious for prostate cancer. If it does, you and your doctor will talk about this, along with risk factors for prostate cancer some men have. These include age, family history of prostate cancer, race and having urinary symptoms. Think about not only the blood test, or possible biopsy (doctors removing tissue from your prostate to test it for cancer) that could come next, but also the possible treatments if prostate cancer is found. If you have a raised PSA, a biopsy will likely be recommended. The raised PSA doesn t automatically mean you have prostate cancer; in fact most biopsies will show that there is no prostate cancer. The main benefit of a biopsy is that it can either rule out prostate cancer or identify higher-risk (more harmful) prostate cancer earlier when treatment may be more effective. The main risk of a biopsy is that it can identify the lower-risk (less harmful) kind of prostate cancer that may not cause health problems in a man s lifetime. It is important to consider that not all lower-risk prostate cancers automatically require treatment. Carefully watching instead of treating right away, known as active surveillance, is a reasonable option for some men. There are tools your doctor can use to better estimate your risk of having prostate cancer the PSA value is one piece of information that is used. This may help you decide whether or not to get a biopsy. Think about what is most important to you, including how old you are and whether or not you have health problems, and what you would do if your PSA level was raised after having a PSA test.
3 INTRODUCTION The PSA test itself is simple. It is a blood sample that can be collected as part of a routine check-up at the doctor s office. The PSA test checks for raised PSA levels in the blood. Raised PSA levels Raised PSA levels are suspicious and could mean prostate cancer They could also be raised for other reasons other than prostate cancer The higher the PSA level the greater the concern that there might be prostate cancer and the chance a biopsy will be recommended As a result PSA screening for prostate cancer is a hot topic. Lower or regular PSA levels The lower the PSA level, the lower the risk of prostate cancer, and especially of unhealthy/high-risk prostate cancer If you have regular levels of PSA, it doesn t automatically mean you don t have prostate cancer There is no level of PSA that guarantees a man does not have prostate cancer 1 THE OPTIONS AFTER RAISED PSA LEVELS Think about: If I get a PSA test done, what will I do if my PSA level comes back as suspicious for prostate cancer? Options include: do nothing, check PSA again after a little while, or have a prostate biopsy Doing nothing If you choose to do nothing and if it turns out later that it is prostate cancer, it may be the kind that is slow growing and doesn t usually cause problems for men in their lifetimes, especially if they are older or have other serious medical conditions. Or, it could be the kind of prostate cancer that grows more quickly and can cause serious problems, including death, if not caught early and treated. (Some prostate cancers can cause serious problems, including death, even if they are caught early and treated.) Checking PSA again after raised PSA levels If you choose to check PSA again later, the test may come back with lower levels, the same levels, or higher levels of PSA. If lower, that s a good sign that there may not be prostate cancer. You may want to have it checked again to see if it stays low. If the levels are the same or higher, the choices are the same as before. Having a biopsy A prostate needle biopsy involves removing and testing cells from your prostate gland. It is generally safe. But, it is a test that invades your body and can cause fever and infection in a small number of men. If the prostate biopsy does find prostate cancer you will have more decisions. The pros and cons of prostate cancer treatment are not part of this decision aid. But, men who get treatment for prostate cancer fall into one of three groups: those whose lives were saved by the treatment, those who were treated unnecessarily because their cancer would never have gotten worse even without treatment, and men whose cancer comes back and gets worse even with treatment. The choices about PSA testing for prostate cancer screening could have a big impact on men s lives. This is why the choice to have a PSA test is an important decision that men should know about and consider carefully with their doctors. Below, the Decision Aid explains the parts of the decision in detail. It describes the possible benefits, such as lowering the risk of dying from prostate cancer and the possible risks, such as unnecessary tests or treatments. 1 Thompson IM, et al., Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level 4.0 ng per Milliliter N Engl J Med 2004;350:
4 BENEFITS AND RISKS OF PSA TESTING Introduction to benefits and risks The information described in this decision is from one study called the European Randomized Study of Screening for Prostate Cancer (ERSPC). The study included 162,388 men, aged 55 to 69 years, who were followed by researchers for 11 years. Half of the men received 2 to 3 PSA tests during that time and half of the men did not get the PSA tests. In this study, men who had a raised PSA higher than a certain level (> 3ng/ml) usually had a biopsy. It is important to note that there is no one set level of PSA to tell us when a biopsy is needed, but usually the higher the amount of PSA in the blood, the more the need for a biopsy to see if it is prostate cancer. The numbers in this decision aid show the benefits and risks, after 11 years of follow-up on average, for men in this study. BENEFITS What is the main potential benefit of having a PSA test? The main possible benefit to getting a PSA test is to find a prostate cancer that would ultimately cause harm, or cause death, when treatment could potentially cure it.* This Decision Aid includes pictographs to show the differences between men who had the tests and men who did not. Each pictograph contains 1000 squares. Each square is equal to 1 person. The numbers in the charts reflect an average risk of dying from or being diagnosed with prostate cancer from the study described above. The chances, for you, may be either higher or lower, based on the stage of the cancer and other clinical factors (such as age and other health conditions). * But, it is difficult to predict for an individual man whether treatment of a prostate cancer found through screening will lead to this benefit.
5 The first set of pictographs, below, show the chances of chance of dying of prostate cancer. These numbers are from the men in the study over an 11 year period. Effect of having PSA test on death from prostate cancer Out of 1000 men who had screening, about 4 died of prostate cancer. Out of 1000 men who did not have screening, about 5 died of prostate cancer. There were about 20% fewer prostate cancer deaths in the men who had PSA screening. 2 Men who Men had who had screening with PSA testing testing Men who Men did who not did have not have screening with PSA PSA testing testing 2 Schröder FH, Hugosson J, Roobol MJ, et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med. 2012;366(11):
6 This set of pictographs show the chances of finding out you have prostate cancer. Chances of being diagnosed with prostate cancer if you have a raised PSA test and a biopsy Out of 1000 men who had screening, about 96 cases of prostate cancer were found. Out of 1000 men who did not have screening, about 60 cases of prostate cancer were found. Men Men who had screening with with PSA testing PSA Men Men who did not have screening with PSA with testing PSA The graphs above mean that screening catches more cases of prostate cancer. By not screening, less cases of prostate cancer are caught. Some of these additional prostate cancers would be the more harmful kind that needs treatment. But, others would be the less harmful kind that would not have caused harm or death over a man s lifetime.
7 RISKS What is the main potential risk of having a PSA test? The main potential risk with PSA testing is that raised results, plus a biopsy, may detect the kind of less harmful prostate cancer that leads to treatment (and its side effects) that wasn t necessary. 1. From the PSA test, one common risk is having a false positive test. This means that the PSA test was positive (the PSA level was raised enough to raise suspicion of prostate cancer) but that the needle biopsy was negative. Approximately 1 out of 3 positive PSA tests turn out to be false positives.* 3 2. From the biopsy, in a small number of men, there can be side effects. The side effects are generally manageable, but in the case of false positive PSA tests, those side effects could have been avoided. Side effects can include serious infection or fever leading to hospitalization, or short-term bleeding in the urine or sperm, or trouble urinating. 3. If the prostate biopsy does detect prostate cancer, it may be a kind of prostate cancer that wouldn t be problem in your lifetime (overdiagnosis). It may be the slow growing kind of prostate cancer. In those cases, the treatment, and the side effects of treatment, wouldn t have been needed (overtreatment). The pictographs below show the chance of having some of the common potential risks with a raised PSA leading to a biopsy. The numbers in the charts reflect an average risk from the study described above. The chances, for you, may be either higher or lower. Hospitalization 4 About 9 men out of 1000 who had a biopsy after a raised PSA were hospitalized for inflammation and/or infection of the prostate. Note: results of another study, with 75,000 men, showed more men being hospitalized than in the past. In 1996, 1% of the men were hospitalized, compared to 4% in * Of about 20,000 men who had biopsies, about 35% were found to have prostate cancer and 65% were found not to have prostate cancer. 3 Ibid. 4 Loeb S, van den Heuvel S, Zhu X, et al. Infectious Complications and Hospital Admissions After Prostate Biopsy in a European Randomized Trial. Eur Urol Jan 5. [Epub ahead of print].
8 Fever About 42 men out of 1000 who had a biopsy after a raised PSA had a fever. Additional side effects Some men get other side effects. They can include short-term pain, bleeding in the urine or sperm, or trouble urinating. If a man is treated for prostate cancer, there can be serious side effects (this tool does not discuss treatment options). You can ask your doctor more about the side effects of biopsy and of prostate cancer treatment. Which men do ASCO experts recommend do or do not have PSA testing? Testing for PSA can be done as part of your routine blood work. For men expected to live 10 or less years, ASCO does not recommend a PSA test because overall it is more likely to be harmful than helpful. For men expected to live more than 10 years, the experts recommend that you think about the pros and cons of screening and consider your values and preferences around issues like biopsies and treatment if the results come back as suspicious for cancer.
9 WEIGHING YOUR OPTIONS The following pages are to help you think about PSA testing as part of prostate cancer screening after you have talked to your doctor. You may want to do this on your own or with someone else (for example, family, friends, or other caregivers outside of the doctor s office). Your test options include: 1. getting PSA testing now, 2. getting PSA testing later, or 3. not getting PSA testing. If PSA is raised, then options include: 1. repeat PSA testing, 2. getting a biopsy, or 3. not getting a biopsy. The next two pages include three steps: 1. What decision do you need to make? 2. What information and help do you need to make the decision? 3. What are the next steps? 1. What decision do you need to make? How soon do you want to make a choice? 2. What information and help do you need to make the decision? Do you know the benefits and risks of each option? If not, what information do you need? Adapted from the Ottawa Personal Decision Guide 2011 O'Connor, Jacobsen, Stacey, University of Ottawa, Ottawa Hospital Research Institute, Canada, by permission.
10 Which benefits and risks matter most to you (please see table below)? In the following table, use the numbers to show how important each benefit and risk is to you. If you circle the number five, then the risk or benefit matters most. If you circle zero, then the risk or benefit matters least. Finally, make a star or asterisk (*) in the column next to the benefit and/or risk(s) that you think are most likely to happen or are most worried about. Potential benefits of PSA testing (including a biopsy): How much does this matter? Please circle a #: [0 (none) 5 (a lot)] How likely is this to happen to you? [0 (none) 5 (a lot)] Ruling out if you have prostate cancer Finding higher-risk prostate cancer earlier when treatment may be more effective Reducing your risk of dying from prostate cancer Potential risks of PSA testing (including a biopsy): From a raised PSA: Getting a prostate biopsy when you do not have prostate cancer From Prostate Biopsy: Identifying prostate cancer that may not have been a problem in your life time Infection Fever Short-term trouble urinating Potential benefits of not having a PSA test Avoiding overdiagnosis and overtreatment Not having to make a decision about having a biopsy if PSA is raised Not having a biopsy and its potential side effects, in cases where the PSA is raised, but there is no prostate cancer Potential risks of not having a PSA test Not finding out if you may have high-risk prostate cancer when it is still potentially curable Other Do you have enough facts to make a choice? If not, what more would you like to know? Do you have enough support and advice from other people to make a choice? If not, who do you want to talk with before making your decision? Are you choosing your treatment option without pressure from others? Adapted from the Ottawa Personal Decision Guide 2011 O'Connor, Jacobsen, Stacey, University of Ottawa, Ottawa Hospital Research Institute, Canada, by permission.
11 3. Plan the next steps Consider planning your next steps based on your needs: a. If you feel you do not have enough support and/or if you feel pressure from others you many want to look for other support. Your doctor, hospital, or clinic may be able to refer you to others who could help you find additional support. b. If you feel you do not have enough facts about PSA testing and/or prostate cancer, you may want to get more. For example, you could visit cancer.net ( Other groups have also created other resources. 4. In the following space, write down any additional other concerns and/or issues that you think are important to your decision (for example, other health issues, your age, money issues, family, etc.): Adapted from the Ottawa Personal Decision Guide 2011 O'Connor, Jacobsen, Stacey, University of Ottawa, Ottawa Hospital Research Institute, Canada, by permission.
12 OTHER RESOURCES Prostate Cancer Risk Calculators for the General Population 1. Prostate Cancer Prevention Trial (PCPT) Prostate Cancer Risk Calculator Sunnybrook Nomogram based prostate cancer risk calculator (SRC) 3. European Randomised Study of Screening for Prostate Cancer (ERSPC) Risk Calculator Screening for Prostate Cancer 1. American Cancer Society. Testing for Prostate Cancer: Should I be tested? Is this the right choice for me? 2. CDC. Prostate Cancer Screening: A Decision Guide (also one specific to African-American men) 2006 pdf decision guides 3. Health Dialog. Is a PSA test right for you? 2011 web booklet and videos 4. Prosdex. University of Cardiff online resource 5. Healthwise Prostate cancer screening: Should I have a PSA test? 2010 decision aid 6. Mayo Clinic Prostate cancer screening: Should you get a PSA test? USPSTF: How to Talk with Your Patients When Evidence Is Insufficient Short Video
Testing for Prostate Cancer Should I be tested? Is it the right choice for me? Prostate cancer affects many men. There are tests to find it early. There may be benefits and risks with testing. Research
Testing for Prostate Cancer Should I be tested? Is it the right choice for me? Prostate cancer affects many men. There are tests to find it early. There may be benefits and risks with testing. Research
For more information, please contact your local VA Medical Center or Health Clinic. U.S. Department of Veterans Affairs Veterans Health Administration Patient Care Services Health Promotion and Disease
Prostate cancer screening It s YOUR decision! For many years now, a test has been available to screen for. The test is called the prostate-specific antigen blood test (or PSA test). It is used in combination
1. What is the prostate-specific antigen (PSA) test? Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. The doctor
Prostate Cancer Screening: Are We There Yet? March 2010 Andrew M.D. Wolf, MD University of Virginia School of Medicine Case #1 A 55 yo white man with well-controlled hypertension presents for his annual
Getting checked for Prostate Cancer Quick guide for men and their families and whanau Stay well for your family and whanau. doctor, nurse or health professional about prostate cancer. You should do this
PSA Testing for Prostate Cancer An information sheet for men considering a PSA Test What is the aim of this leaflet? Prostate cancer is a serious condition. The PSA test, which can give an early indication
Prostate Cancer Screening Bruce L. Houghton, MD Associate Professor of Medicine Division of General Medicine Department of Internal Medicine Creighton University School of Medicine http://en.wikipedia.org/wiki/image:prostatelead.jpg
Prostate Cancer Screening A Decision Guide for African Americans This booklet was developed by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC). Published
PROSTATE CANCER 1. Guidelines for Screening Risk Factors Normal-risk men: No family history of prostate cancer No history of prior screening Not African-American High-risk men: Family history of prostate
All men should know they are having a PSA test and be informed of the implications prior to testing. This booklet was created to help primary care providers offer men information about the risks and benefits
Official reprint from UpToDate www.uptodate.com 2013 UpToDate The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek
The Centers for Medicare & Medicaid Services (CMS) seeks stakeholder comments on the following clinical quality measure under development: Title: Non-Recommended PSA-Based Screening Description: The percentage
PSA Screening and the USPSTF Understanding the Controversy Peter C. Albertsen Division of Urology University of Connecticut Farmington, CT, USA USPSTF Final Report 1 Four Key Questions 1. Does PSA based
Cancer in Primary Care: Prostate Cancer Screening How and How often? Should we and in which patients? PLCO trial (Prostate, Lung, Colorectal and Ovarian) Results In the screening group, rates of compliance
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Early Prostate Cancer:
Cancer Care Ontario: Prostate Cancer Screening with the Prostate- Specific Antigen (PSA) Test Key Messages for Healthcare Providers Considerations for men at average risk Avoid prostate-specific antigen
Cancer Expert Working Group on Cancer Prevention and Screening Screening for Prostate Cancer Information for men and their families 1 What is the prostate? 2 What is prostate cancer? prostate The prostate
How prostate cancer is diagnosed This information is an extract from the booklet Having tests for prostate cancer. You may find the full booklet helpful. We can send you a free copy see page 7. Contents
Clinical and Experimental Medical Sciences, Vol. 1, 2013, no. 3, 111 116 HIKARI Ltd, www.m-hikari.com Role of MRI in the Diagnosis of Prostate Cancer, A Proposal W. Akhter Research Fellow Urology, Bartshealth
Advice to patients about the PSA (prostate-specific antigen) blood test: frequently-asked questions What is the PSA blood test? If you want more information before deciding to have this test, it is important
An Introduction to PROSTATE CANCER Being diagnosed with prostate cancer can be a life-altering experience. It requires making some very difficult decisions about treatments that can affect not only the
Prostate Cancer Screening The American Cancer Society and Congregational Health Ministry Team June Module To access this module via the Web, visit www.cancer.org and type in congregational health ministry
Screening for Prostate Cancer It is now clear that screening for Prostate Cancer discovers the disease at an earlier and more curable stage. It is not yet clear whether this translates into reduced mortality
Talking about Prostate Cancer Talking about Prostate Cancer If I can avoid going to a doctor, I will but not when we re talking about prostate cancer. Why take chances with a condition that might be serious?
PSA Testing 101 Stanley H. Weiss, MD Professor, UMDNJ-New Jersey Medical School Director & PI, Essex County Cancer Coalition email@example.com September 23, 2010 Screening: 3 tests for PCa A good screening
Prostate Cancer Screening in Taiwan: a must 吳 俊 德 基 隆 長 庚 醫 院 台 灣 醫 學 會 105 th What is the PSA test? The blood level of PSA is often elevated in men with prostate cancer, and the PSA test was originally
FAQ About Prostate Cancer Treatment and SpaceOAR System P. 4 Prostate Cancer Background SpaceOAR Frequently Asked Questions (FAQ) 1. What is prostate cancer? The vast majority of prostate cancers develop
Prostate Cancer: Screening Update Middlesex Hospital Cancer Center Comprehensive Prostate Cancer Program Edward G. Myer, M.D. Middlesex Urology, P.C. October 15, 2015 Middlesex Hospital Cancer Center Comprehensive
Pre-test Audience Response Screening and Treatment of Prostate Cancer: The 2013 Perspective 1. I do not offer routine PSA screening, and the USPSTF D recommendation will not change my practice. 2. In light
Prostate cancer Christopher Eden The Royal Surrey County Hospital, Guildford & The Hampshire Clinic, Old Basing. Screening Screening men for PCa (prostate cancer) using PSA (Prostate Specific Antigen blood
The PSA Controversy: Defining It, Discussing It, and Coping With It 11 TH ANNUAL SYMPOSIUM ON MEN S HEALTH June 12, 2013 The PSA Controversy Defining It, Discussing It and Coping With It As of May 2012,
Update on Prostate Cancer: Screening, Diagnosis, and Treatment Making Sense of the Noise and Directions Forward 33 rd Annual Internal Medicine Update December 5, 2015 Ryan C. Hedgepeth, MD, MS Chief of
Controversites: Screening for Prostate Cancer in Older Adults William Dale, MD, PhD University of Chicago Sections of Geriatrics & Palliative Medicine and Hematology/Oncology Director, Specialized Oncology
PSA Test Provides the Early Prostate Cancer Detection That Has Saved the Life of Thousands of Men Table of Contents 1. What the research shows on the effectiveness of the PSA test p. 2 2. PSA test guidelines
Radical Prostatectomy Table of Contents Surgery Overview What To Expect After Surgery Why It Is Done How Well It Works Risks What To Think About References Credits Surgery Overview A radical prostatectomy
PSA Screening For Prostate Cancer: Yes Or No? The United States Preventive Services Task Force issued a recommendation that healthy men should no longer receive PSA testing as part of routine cancer screening.
PCA3 DETECTION TEST FOR PROSTATE CANCER DO YOU KNOW YOUR RISK OF HAVING CANCER? PCA3 DETECTION TEST FOR PROSTATE CANCER There is a range of methods available to your healthcare professional to verify the
Prostate Cancer Screening Dr. J. McCracken, Urologist USPSTF Lifetime risk for diagnosis currently estimated at 15.9% Llifetime risk of dying of prostate cancer is 2.8% Seventy percent of deaths due to
A start to help you understand prostate cancer If you are reading this because you have worries or concerns about yourself or someone you know then the best thing to do is make an appointment with your
Screening for Prostate Cancer Review against programme appraisal criteria for the UK National Screening Committee (UK NSC) Version 1: This document summarises the work of ScHARR 1 2 and places it against
Overuse of PSA Screening for Prostate Cancer in Older Men Elizabeth Jaramillo, MD January 17, 2014 Screening Prostate cancer screening occurs in patients with no clinical sign or suspicion of disease Screening
A.D.A.M. Medical Encyclopedia. Prostate cancer Cancer - prostate; Biopsy - prostate; Prostate biopsy; Gleason score Last reviewed: October 2, 2013. Prostate cancer is cancer that starts in the prostate
Prostate-Specific Antigen Based Screening: Controversy and Guidelines Eric H. Kim and Gerald L. Andriole Institutional Address: Washington University School of Medicine 4960 Children's Place Campus Box
DECISION AID SET STAGE IV Non-Small Cell Lung Cancer (NSCLC) Dear Clinician: This set of DECISION AIDS is based on ASCO s Clinical Practice Guideline Update on Chemotherapy for Stage IV NSCLC (2009). ASCO
Oncology Annual Report: Prostate Cancer 25 Update By: John Konefal, MD, Radiation Oncology Prostate cancer is the most common cancer in men, with 232,9 new cases projected to be diagnosed in the U.S. in
TO SCREEN OR NOT TO SCREEN: THE PROSTATE CANCER DILEMMA Thomas J Stormont MD January 2012 http://www.youtube.com/watch?v=8jd 7bAHVp0A&feature=related related INTRODUCTION A government health panel (the
Thomas A. Kollmorgen, M.D. Oregon Urology Institute None 240,000 new diagnosis per year, and an estimated 28,100 deaths (2012) 2 nd leading cause of death from cancer in U.S.A. Approximately 1 in 6 men
Understanding The PSA Test Understanding the PSA test This booklet has been written to help you understand more about PSA (prostate specific antigen), the test and its relevance to the diagnosis and treatment
www.medscape.com Update on Prostate Cancer Screening Guidelines Christine Gonzalez, PharmD, CHHC US Pharmacist Abstract and Introduction Introduction In the United States, prostate cancer is the most common
Virtual Mentor American Medical Association Journal of Ethics January 2011, Volume 13, Number 1: 10-15. CLINICAL CASE The Debate Over Prostate Cancer Screening Guidelines Commentary by Karen E. Hoffman,
Clinical Practice Guidelines and Shared Decision Making for Prostate Cancer Screening Dr. Roger Luckmann Associate Professor Family Medicine and Community Health UMass Medical School Disclosures I have
November 25, 2015 Men's Health Network P. O. Box 75972 Washington, D.C. 20013 202-543-MHN-1 (6461) Fax 202-543-2727 Albert L Siu, MD, MSPH Chair, US Preventive Services Task Force 5600 Fishers Lane, Mail
Hard decisions about cancer 5 tests and treatments to question When the diagnosis is cancer, many people understandably want to pull out all the stops to treat it. But some tests, treatments, and procedures
Prostate Cancer Early Detection: Update 2010 Prostate Cancer. Disease Burden The most common non-skin cancer, and the second leading cause of cancer death among U.S. men It is estimated that: 1 in 6 men
Prevention Series Prostate Cancer How to reduce your risk Let's Make Cancer History 1 888 939-3333 www.cancer.ca Prostate Cancer How to reduce your risk Prostate cancer is the most common cancer in Canadian
Understanding the PSA test A guide for men concerned about prostate cancer Introduction This booklet is for men who want to know more about having a blood test, called a PSA test, that can help diagnose
Screening for Cancer in Light of New Guidelines and Controversies Christopher Celio, MD St. Jude Heritage Medical Group Screening Tests The 2 major objectives of a good screening program are: (1) detection
TO PROVIDE THE VERY BEST CARE FOR EACH PATIENT ON EVERY OCCASION Prostate Specific Antigen (PSA) Blood Test An information guide Prostate Specific Antigen (PSA) Blood Test Prostate Specific Antigen (PSA)
The 4Kscore blood test for risk of aggressive prostate cancer Early detection of aggressive prostate cancer Challenges Serum PSA has a high false positive rate Over 1 million prostate biopsies performed
About Cancer Cancer is a disease where there is a disturbance in the normal pattern of cell replacement. The cells mutate and become abnormal or grow uncontrollably. Not all tumours are cancerous (i.e.
Prostate Cancer Information and Facts Definition Prostate cancer is cancer that starts in the prostate gland. The prostate is a small, walnutsized structure that makes up part of a man's reproductive system.
The 2014 Cancer Program Annual Public Reporting of Outcomes/Annual Site Analysis Statistical Data from 2013 More than 70 percent of all newly diagnosed cancer patients are treated in the more than 1,500
Defending PSA Re-Thinking the USPSTF Recommendations for Prostate Cancer Screening Steven Bereta, MS, RN, FNP-C Disclosure I do not have affiliations with any corporate organization that may constitute
PSA: Screening for Prostate Cancer in Older Adults William Dale, MD, PhD University of Chicago Sections of Geriatrics & Palliative Medicine and Hematology/Oncology Director, Specialized Oncology Care &
Early Detection of Prostate Cancer: How to do it smart Laurence Klotz Sunnybrook Health Sciences Centre Professor of Surgery University of Toronto If screening was a pill: You are a 60 year old male and
Corporate Medical Policy Saturation Biopsy for Diagnosis and Staging of Prostate Cancer File Name: Origination: Last CAP Review: Next CAP Review: Last Review: saturation_biopsy_for_diagnosis_and_staging_of_prostate_cancer
WHEN PROSTATE CANCER RETURNS: ADVANCED PROSTATE CANCER (The following information is based on the general experiences of many prostate cancer patients. Your experience may be different.) How Will I Know
Transrectal Ultrasound (Trus) Guided Prostate Biopsies Urology Patient Information Leaflet Page 1 What is the purpose of my appointment? Your doctor has informed us that you have an elevated Prostate Specific
The 4Kscore blood test for risk of aggressive prostate cancer Prostate cancer tests When to use the 4Kscore Test? Screening Prior to 1 st biopsy Prior to negative previous biopsy Prognosis in Gleason 6
Oxford University Hospitals NHS Trust Oxford Regional Genetic Department BRCA1 and BRCA2 for men Information for men from families with a known alteration in the BRCA1/2 gene Introduction BRCA1 and BRCA2
Cancer research in the Midland Region the prostate and bowel cancer projects Ross Lawrenson Waikato Clinical School University of Auckland MoH/HRC Cancer Research agenda Lung cancer Palliative care Prostate
Cervical cancer screening with the HPV test and the Pap test in women ages 30 and older When to get tested and how to make sense of your test results If you are 30 years or older and your Pap test is normal
Patient information from the BMJ Group Bowel cancer: should I be screened? Bowel cancer is a serious condition, but there are good treatments. Treatment works best if it's started early.to pick up early
Prostate Cancer Screening: What We ve Learned and Where we should go Gerald L. Andriole, MD Robert K. Royce Distinguished Professor Chief of Urologic Surgery Siteman Cancer Center Washington University
For more infomation about Cancer Clinical Trials at Upstate Cancer Center please call Upstate Connect 1.800.464.8668 TAKING PART IN CANCER TREATMENT RESEARCH STUDIES Information provided by: National Cancer
Facing Prostate Cancer Surgery? Learn about minimally invasive da Vinci Surgery The Condition: Prostate Cancer Your prostate is a walnut-sized gland that is part of the male reproductive system. The prostate
PROSTATE CANCER 101 WHAT IS PROSTATE CANCER? Prostate cancer is cancer that begins in the prostate. The prostate is a walnut-shaped gland in the male reproductive system located below the bladder and in
What women should know about cervical cancer and the human papilloma virus American Cancer Society Guidelines for the Early Detection of Cervical Cancer I take care of myself so I can take care of my family.
National Cancer Institute Taking Part in Cancer Treatment Research Studies U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Taking Part in Cancer Treatment Research Studies If